National Express Group (OTCMKTS:NXPGF) Lifted to “Hold” at Zacks Investment Research

Share on StockTwits

Zacks Investment Research upgraded shares of National Express Group (OTCMKTS:NXPGF) from a sell rating to a hold rating in a report released on Tuesday morning, Zacks.com reports.

According to Zacks, “National Express Group plc is a transport operator. It provides bus, coach and rail services primarily in the UK, Continental Europe, North Africa, North America and the Middle East. National Express Group plc is based in Birmingham, United Kingdom. “

OTCMKTS NXPGF opened at $5.00 on Tuesday. The business’s 50 day moving average price is $5.05. National Express Group has a 1-year low of $5.00 and a 1-year high of $5.15.

National Express Group Company Profile

National Express Group PLC provides public transport services in the United Kingdom, Continental Europe, North Africa, North America, and the Middle East. The company operates through UK, German Rail, ALSA, and North America segments. It owns and leases buses, coaches, and trains to deliver local, regional, national, and international transportation services.

Featured Story: How can you know how many shares are floating?

Get a free copy of the Zacks research report on National Express Group (NXPGF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for National Express Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Express Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

E.ON SE Sponsored ADR   Upgraded at Zacks Investment Research
E.ON SE Sponsored ADR Upgraded at Zacks Investment Research
MITIE GRP PLC/ADR  Downgraded by Zacks Investment Research
MITIE GRP PLC/ADR Downgraded by Zacks Investment Research
Hammerson  Upgraded by Royal Bank of Canada to “Outperform”
Hammerson Upgraded by Royal Bank of Canada to “Outperform”
National Express Group  Lifted to “Hold” at Zacks Investment Research
National Express Group Lifted to “Hold” at Zacks Investment Research
Axovant Gene Therapies  Upgraded to “Outperform” by Robert W. Baird
Axovant Gene Therapies Upgraded to “Outperform” by Robert W. Baird
HC Wainwright Downgrades Melinta Therapeutics  to Neutral
HC Wainwright Downgrades Melinta Therapeutics to Neutral


 
© 2006-2019 Zolmax.